​

Unity Bio (UBX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Unity Bio Revenue Highlights

00

Unity Bio Revenue by Period

Unity Bio Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$236.00K-95.07%
2021-12-31$4.78M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--100.00%
2017-12-31$1.38M100.00%
2016-12-31--

Unity Bio generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Unity Bio Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.90M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$-236.00K100.00%
2022-09-30--100.00%
2022-06-30$236.00K100.00%
2022-03-31--100.00%
2021-12-31$4.78M100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$105.50M100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$1.38M100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Unity Bio generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Unity Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OVIDOvid Therapeutics$391.69M$173.00K
BEAMBeam Therapeutics$377.71M$14.27M
HRTXHeron Therapeutics$127.04M$36.02M
RXRXRecursion Pharmaceuticals$44.58M$14.42M
NTLAIntellia Therapeutics$36.27M$9.11M
HOOKHOOKIPA Pharma$20.13M-
VERVVerve Therapeutics$11.76M$6.87M
RNAAvidity Biosciences$9.56M$2.04M
ENSCEnsysce Biosciences$2.23M-
EDITEditas Medicine--
CNTBConnect Biopharma--
PRMEPrime Medicine-$39.31M
ABOSAcumen Pharmaceuticals--
NXTCNextCure--
DRMADermata Therapeutics--
UBXUnity Bio--
NUVBNuvation Bio-$727.00K
WINTWindtree Therapeutics--
AVIRAtea Pharmaceuticals--

UBX Revenue FAQ

What is Unity Bio’s yearly revenue?

Unity Bio's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $236K, representing a decrease of -95.07% compared to 2021. UBX's yearly revenue for 2021 was $4.78M, representing an increase of 100.00% compared to 2020.

What is Unity Bio’s quarterly revenue?

Unity Bio's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). UBX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Unity Bio’s revenue growth rate?

Unity Bio's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.